secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001213900-23-067061
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Q3 FY2023 product revenue $630K, up from $32K; net loss $3.5M
----------------------------------------------------------------------

- Product revenue $630K in Q3 FY2023 vs $32K YoY; collaboration revenue $1.46M in 9M.
- Net loss $3.5M in Q3 vs $2.8M prior year; cash $3.1M at June 30 vs $8.1M at Sept 30.
- Evo sEEG limited launch completed; full launch with Zimmer Biomet expected Q4. OneRF 510(k) submitted June 8.
- Closed public offering net $5.2M and ATM net $2.5M in July 2023; no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023067061/0001213900-23-067061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023067061/ea183383-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-067061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer